NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Prognostic Value of Three New Biomarkers of Multiple Sclerosis in Patients With Radiologically Isolated Syndrome
Prognostic Value of Three New Biomarkers of Multiple Sclerosis in Patients With Radiologically Isolated Syndrome

NCT03357887

CompletedN/A

Sponsor: Centre Hospitalier Universitaire de Nīmes

Conditions: Multiple Sclerosis, Radiologically Isolated Syndrome

Interventions: Analysis of cerebrospinal fluid and serum

Countries: France

To look at the prognostic value of new biomarkers in CSF and serum for characterisation of multiple sclerosis

Eligibility overview

Sex: ALL

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion criteria

* Patients have given their free consent for use of their samples in research
* Patients have at least 2 years of clinical and radiological follow-up data available Exclusion criterion
* No follow-up of patients
Locations (1)
  • Nîmes, France